TERM ID="NYU_TERM_1" STRING="CTX" FREQUENCY=9 START=751 END=754 LEMMA="CETUXIMAB " LEMMA_FREQUENCY=10
TERM ID="NYU_TERM_2" STRING="CTX" FREQUENCY=9 START=761 END=764 LEMMA="CETUXIMAB " LEMMA_FREQUENCY=10
TERM ID="NYU_TERM_3" STRING="CTX" FREQUENCY=9 START=787 END=790 LEMMA="CETUXIMAB " LEMMA_FREQUENCY=10
TERM ID="NYU_TERM_4" STRING="CTX" FREQUENCY=9 START=829 END=832 LEMMA="CETUXIMAB " LEMMA_FREQUENCY=10
TERM ID="NYU_TERM_5" STRING="CTX" FREQUENCY=9 START=1423 END=1426 LEMMA="CETUXIMAB " LEMMA_FREQUENCY=10
TERM ID="NYU_TERM_6" STRING="CTX" FREQUENCY=9 START=1434 END=1437 LEMMA="CETUXIMAB " LEMMA_FREQUENCY=10
TERM ID="NYU_TERM_7" STRING="CTX" FREQUENCY=9 START=2136 END=2139 LEMMA="CETUXIMAB " LEMMA_FREQUENCY=10
TERM ID="NYU_TERM_8" STRING="CTX" FREQUENCY=9 START=2801 END=2804 LEMMA="CETUXIMAB " LEMMA_FREQUENCY=10
TERM ID="NYU_TERM_9" STRING="CTX" FREQUENCY=9 START=2819 END=2822 LEMMA="CETUXIMAB " LEMMA_FREQUENCY=10
TERM ID="NYU_TERM_10" STRING="CTX arm" FREQUENCY=1 START=2024 END=2031 LEMMA="CTX ARM" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_11" STRING="Cetuximab" FREQUENCY=2 START=0 END=9 LEMMA="CETUXIMAB" LEMMA_FREQUENCY=9
TERM ID="NYU_TERM_12" STRING="Cetuximab" FREQUENCY=2 START=772 END=781 LEMMA="CETUXIMAB" LEMMA_FREQUENCY=9
TERM ID="NYU_TERM_13" STRING="Clinical Excellence" FREQUENCY=1 START=423 END=442 LEMMA="CLINICAL EXCELLENCE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_14" STRING="Erbitux" FREQUENCY=1 START=621 END=628 LEMMA="ERBITUX" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_15" STRING="First-Line Treatment" FREQUENCY=1 START=632 END=652 LEMMA="FIRST-LINE TREATMENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_16" STRING="ICER" FREQUENCY=2 START=1729 END=1733 LEMMA="INCREMENTAL COST EFFECTIVENESS RATIO" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_17" STRING="ICER" FREQUENCY=2 START=2063 END=2067 LEMMA="INCREMENTAL COST EFFECTIVENESS RATIO" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_18" STRING="Markov model" FREQUENCY=1 START=1357 END=1369 LEMMA="MARKOV MODEL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_19" STRING="Metastatic Head" FREQUENCY=1 START=669 END=684 LEMMA="METASTATIC HEAD" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_20" STRING="PFS" FREQUENCY=1 START=977 END=980 LEMMA="PROGRESSION FREE SURVIVAL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_21" STRING="Probabilistic sensitivity analysis" FREQUENCY=1 START=2069 END=2103 LEMMA="PROBABILISTIC SENSITIVITY ANALYSIS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_22" STRING="QALY" FREQUENCY=2 START=1785 END=1789 LEMMA="QUALITY ADJUSTED LIFE YEAR" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_23" STRING="QALY" FREQUENCY=2 START=2324 END=2328 LEMMA="QUALITY ADJUSTED LIFE YEAR" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_24" STRING="RCT" FREQUENCY=2 START=606 END=609 LEMMA="RANDOMISED CONTROLLED TRIAL" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_25" STRING="RCT" FREQUENCY=2 START=2650 END=2653 LEMMA="RANDOMISED CONTROLLED TRIAL" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_26" STRING="SCCHN" FREQUENCY=1 START=322 END=327 LEMMA="SCCHN" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_27" STRING="STA" FREQUENCY=2 START=494 END=497 LEMMA="SINGLE TECHNOLOGY APPRAISAL" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_28" STRING="STA" FREQUENCY=2 START=2602 END=2605 LEMMA="SINGLE TECHNOLOGY APPRAISAL" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_29" STRING="Subgroup" FREQUENCY=1 START=1610 END=1618 LEMMA="SUBGROUP" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_30" STRING="Univariate sensitivity analysis" FREQUENCY=1 START=1861 END=1892 LEMMA="UNIVARIATE SENSITIVITY ANALYSIS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_31" STRING="appropriateness" FREQUENCY=2 START=2368 END=2383 LEMMA="APPROPRIATENES" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_32" STRING="appropriateness" FREQUENCY=2 START=2556 END=2571 LEMMA="APPROPRIATENES" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_33" STRING="appropriateness of economic modelling" FREQUENCY=1 START=2556 END=2593 LEMMA="ECONOMIC MODELLING APPROPRIATENES" LEMMA_FREQUENCY=1 HEAD_TERM="appropriateness" HEAD_LEMMA="APPROPRIATENES"
TERM ID="NYU_TERM_34" STRING="base-case cost-effectiveness results" FREQUENCY=1 START=1514 END=1550 LEMMA="BASE-CASE COST-EFFECTIVENESS RESULT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_35" STRING="cetuximab" FREQUENCY=7 START=234 END=243 LEMMA="CETUXIMAB" LEMMA_FREQUENCY=9
TERM ID="NYU_TERM_36" STRING="cetuximab" FREQUENCY=7 START=1243 END=1252 LEMMA="CETUXIMAB" LEMMA_FREQUENCY=9
TERM ID="NYU_TERM_37" STRING="cetuximab" FREQUENCY=7 START=1408 END=1417 LEMMA="CETUXIMAB" LEMMA_FREQUENCY=9
TERM ID="NYU_TERM_38" STRING="cetuximab" FREQUENCY=7 START=2009 END=2018 LEMMA="CETUXIMAB" LEMMA_FREQUENCY=9
TERM ID="NYU_TERM_39" STRING="cetuximab" FREQUENCY=7 START=2121 END=2130 LEMMA="CETUXIMAB" LEMMA_FREQUENCY=9
TERM ID="NYU_TERM_40" STRING="cetuximab" FREQUENCY=7 START=2786 END=2795 LEMMA="CETUXIMAB" LEMMA_FREQUENCY=9
TERM ID="NYU_TERM_41" STRING="cetuximab" FREQUENCY=7 START=2869 END=2878 LEMMA="CETUXIMAB" LEMMA_FREQUENCY=9
TERM ID="NYU_TERM_42" STRING="cetuximab " FREQUENCY=1 START=722 END=732 LEMMA="CETUXIMAB " LEMMA_FREQUENCY=10
TERM ID="NYU_TERM_43" STRING="clinical data" FREQUENCY=1 START=1451 END=1464 LEMMA="CLINICAL DATA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_44" STRING="clinical effectiveness" FREQUENCY=1 START=185 END=207 LEMMA="CLINICAL EFFECTIVENESS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_45" STRING="comparing cetuximab" FREQUENCY=1 START=712 END=731 LEMMA="COMPARING CETUXIMAB" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_46" STRING="controlled trial" FREQUENCY=1 START=588 END=604 LEMMA="CONTROLLED TRIAL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_47" STRING="cost-effectiveness" FREQUENCY=3 START=212 END=230 LEMMA="COST-EFFECTIVENESS" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_48" STRING="cost-effectiveness" FREQUENCY=3 START=1386 END=1404 LEMMA="COST-EFFECTIVENESS" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_49" STRING="cost-effectiveness" FREQUENCY=3 START=2928 END=2946 LEMMA="COST-EFFECTIVENESS" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_50" STRING="cost-effectiveness of cetuximab" FREQUENCY=2 START=212 END=243 LEMMA="CETUXIMAB COST-EFFECTIVENESS" LEMMA_FREQUENCY=2 HEAD_TERM="cost-effectiveness" HEAD_LEMMA="COST-EFFECTIVENESS"
TERM ID="NYU_TERM_51" STRING="cost-effectiveness of cetuximab" FREQUENCY=2 START=1386 END=1417 LEMMA="CETUXIMAB COST-EFFECTIVENESS" LEMMA_FREQUENCY=2 HEAD_TERM="cost-effectiveness" HEAD_LEMMA="COST-EFFECTIVENESS"
TERM ID="NYU_TERM_52" STRING="day-case infusion" FREQUENCY=1 START=1925 END=1942 LEMMA="DAY-CASE INFUSION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_53" STRING="disease control rate" FREQUENCY=1 START=1062 END=1082 LEMMA="DISEASE CONTROL RATE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_54" STRING="economic model" FREQUENCY=1 START=2349 END=2363 LEMMA="ECONOMIC MODEL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_55" STRING="economic modelling" FREQUENCY=1 START=2575 END=2593 LEMMA="ECONOMIC MODELLING" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_56" STRING="evidence review group" FREQUENCY=1 START=141 END=162 LEMMA="EVIDENCE REVIEW GROUP" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_57" STRING="high-quality" FREQUENCY=1 START=564 END=576 LEMMA="HIGH-QUALITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_58" STRING="incremental cost" FREQUENCY=1 START=1805 END=1821 LEMMA="INCREMENTAL COST" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_59" STRING="incremental cost-effectiveness ratio" FREQUENCY=2 START=1691 END=1727 LEMMA="INCREMENTAL COST-EFFECTIVENESS RATIO" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_60" STRING="incremental cost-effectiveness ratio" FREQUENCY=2 START=1691 END=1727 LEMMA="INCREMENTAL COST-EFFECTIVENESS RATIO" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_61" STRING="life-year" FREQUENCY=2 START=1774 END=1783 LEMMA="LIFE-YEAR" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_62" STRING="life-year" FREQUENCY=2 START=1826 END=1835 LEMMA="LIFE-YEAR" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_63" STRING="manufacturer" FREQUENCY=4 START=355 END=368 LEMMA="MANUFACTURER" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_64" STRING="manufacturer" FREQUENCY=4 START=1307 END=1319 LEMMA="MANUFACTURER" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_65" STRING="manufacturer" FREQUENCY=4 START=1666 END=1678 LEMMA="MANUFACTURER" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_66" STRING="manufacturer" FREQUENCY=4 START=2903 END=2916 LEMMA="MANUFACTURER" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_67" STRING="metastatic SCCHN" FREQUENCY=2 START=2208 END=2224 LEMMA="METASTATIC SCCHN" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_68" STRING="metastatic SCCHN" FREQUENCY=2 START=2707 END=2723 LEMMA="METASTATIC SCCHN" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_69" STRING="metastatic squamous cell carcinoma" FREQUENCY=2 START=48 END=82 LEMMA="METASTATIC SQUAMOUS CELL CARCINOMA" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_70" STRING="metastatic squamous cell carcinoma" FREQUENCY=2 START=265 END=299 LEMMA="METASTATIC SQUAMOUS CELL CARCINOMA" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_71" STRING="parametric survival projection" FREQUENCY=1 START=2403 END=2433 LEMMA="PARAMETRIC SURVIVAL PROJECTION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_72" STRING="primary outcome" FREQUENCY=1 START=846 END=861 LEMMA="PRIMARY OUTCOME" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_73" STRING="progression-free survival" FREQUENCY=2 START=950 END=975 LEMMA="PROGRESSION-FREE SURVIVAL" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_74" STRING="progression-free survival" FREQUENCY=2 START=950 END=975 LEMMA="PROGRESSION-FREE SURVIVAL" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_75" STRING="quality-adjusted life-year" FREQUENCY=1 START=1757 END=1783 LEMMA="QUALITY-ADJUSTED LIFE-YEAR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_76" STRING="randomised controlled trial" FREQUENCY=1 START=577 END=604 LEMMA="RANDOMISED CONTROLLED TRIAL" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_77" STRING="secondary outcomes" FREQUENCY=1 START=928 END=946 LEMMA="SECONDARY OUTCOME" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_78" STRING="secondary outcomes of progression-free survival" FREQUENCY=1 START=928 END=975 LEMMA="PROGRESSION-FREE SURVIVAL SECONDARY OUTCOME" LEMMA_FREQUENCY=1 HEAD_TERM="secondary outcomes" HEAD_LEMMA="SECONDARY OUTCOME"
TERM ID="NYU_TERM_79" STRING="single technology appraisal" FREQUENCY=1 START=465 END=492 LEMMA="SINGLE TECHNOLOGY APPRAISAL" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_80" STRING="squamous cell carcinoma of the head and neck" FREQUENCY=1 START=276 END=320 LEMMA="SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_81" STRING="stable/response health state" FREQUENCY=1 START=1973 END=2001 LEMMA="STABLE/RESPONSE HEALTH STATE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_82" STRING="stable/response health state of the cetuximab" FREQUENCY=1 START=1973 END=2018 LEMMA="CETUXIMAB STABLE/RESPONSE HEALTH STATE" LEMMA_FREQUENCY=1 HEAD_TERM="stable/response health state" HEAD_LEMMA="STABLE/RESPONSE HEALTH STATE"
TERM ID="NYU_TERM_83" STRING="survival benefit" FREQUENCY=1 START=2764 END=2780 LEMMA="SURVIVAL BENEFIT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_84" STRING="technology appraisal" FREQUENCY=1 START=472 END=492 LEMMA="TECHNOLOGY APPRAISAL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_85" STRING="threshold analyses" FREQUENCY=1 START=1623 END=1641 LEMMA="THRESHOLD ANALYSIS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_86" STRING="time-to-treatment failure" FREQUENCY=1 START=1106 END=1131 LEMMA="TIME-TO-TREATMENT FAILURE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_87" STRING="trial data" FREQUENCY=1 START=2457 END=2467 LEMMA="TRIAL DATA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_88" STRING="two-arm state-transition" FREQUENCY=1 START=1332 END=1356 LEMMA="TWO-ARM STATE-TRANSITION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_89" STRING="two-arm state-transition Markov model" FREQUENCY=1 START=1332 END=1369 LEMMA="MARKOV MODEL TWO-ARM STATE-TRANSITION" LEMMA_FREQUENCY=1 HEAD_TERM="Markov model" HEAD_LEMMA="MARKOV MODEL"
TERM ID="NYU_TERM_90" STRING="utility values" FREQUENCY=1 START=1951 END=1965 LEMMA="UTILITY VALUE" LEMMA_FREQUENCY=1
